Dual-use capabilities of concern of biological AI models

As a result of rapidly accelerating artificial intelligence (AI) capabilities, multiple national governments and multinational bodies have launched efforts to address safety, security and ethics issues related to AI models. One high priority among these efforts is the mitigation of misuse of AI models, such as for the development of chemical, biological, nuclear or radiological (CBRN) threats. Many biologists have for decades sought to reduce the risks of scientific research that could lead, through accident or misuse, to high-consequence disease outbreaks. Scientists have carefully considered what types of life sciences research have the potential for both benefit and risk (dual use), especially as scientific advances have accelerated our ability to engineer organisms. Here we describe how previous experience and study by scientists and policy professionals of dual-use research in the life sciences can inform dual-use capabilities of AI models trained using biological data. Of these dual-use capabilities, we argue that AI model evaluations should prioritize addressing those which enable high-consequence risks (i.e., large-scale harm to the public, such as transmissible disease outbreaks that could develop into pandemics), and that these risks should be evaluated prior to model deployment so as to allow potential biosafety and/or biosecurity measures. While biological research is on balance immensely beneficial, it is well recognized that some biological information or technologies could be intentionally or inadvertently misused to cause consequential harm to the public. AI-enabled life sciences research is no different. Scientists' historical experience with identifying and mitigating dual-use biological risks can thus help inform new approaches to evaluating biological AI models. Identifying which AI capabilities pose the greatest biosecurity and biosafety concerns is necessary in order to establish targeted AI safety evaluation methods, secure these tools against accident and misuse, and avoid impeding immense potential benefits.

Authors

Institutions

Publication Details

Journal
PLoS Computational Biology
Published
2025-05-08
DOI
https://doi.org/10.1371/journal.pcbi.1012975
Citations
17
Primary Topic
Bacillus and Francisella bacterial research
Type
article
Field-Weighted Citation Impact
12.90
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dual-use capabilities of concern of biological AI models

Jaspreet Pannu, Gabriel dos Passos Gomes, Anita Cicero, Robert MacKnight et al.
17 citations
PLoS Computational Biology
Bacillus and Francisella bacterial research
12.90
article

Dual-use capabilities of concern of biological AI models

Jaspreet Pannu, Gabriel dos Passos Gomes, Anita Cicero, Robert MacKnight, Magda‐Viola Hanke, Alex W Zhu, Doni Bloomfield, Thomas V. Inglesby
article en
17 citations

Abstract

As a result of rapidly accelerating artificial intelligence (AI) capabilities, multiple national governments and multinational bodies have launched efforts to address safety, security and ethics issues related to AI models. One high priority among these efforts is the mitigation of misuse of AI models, such as for the development of chemical, biological, nuclear or radiological (CBRN) threats. Many biologists have for decades sought to reduce the risks of scientific research that could lead, through accident or misuse, to high-consequence disease outbreaks. Scientists have carefully considered what types of life sciences research have the potential for both benefit and risk (dual use), especially as scientific advances have accelerated our ability to engineer organisms. Here we describe how previous experience and study by scientists and policy professionals of dual-use research in the life sciences can inform dual-use capabilities of AI models trained using biological data. Of these dual-use capabilities, we argue that AI model evaluations should prioritize addressing those which enable high-consequence risks (i.e., large-scale harm to the public, such as transmissible disease outbreaks that could develop into pandemics), and that these risks should be evaluated prior to model deployment so as to allow potential biosafety and/or biosecurity measures. While biological research is on balance immensely beneficial, it is well recognized that some biological information or technologies could be intentionally or inadvertently misused to cause consequential harm to the public. AI-enabled life sciences research is no different. Scientists' historical experience with identifying and mitigating dual-use biological risks can thus help inform new approaches to evaluating biological AI models. Identifying which AI capabilities pose the greatest biosecurity and biosafety concerns is necessary in order to establish targeted AI safety evaluation methods, secure these tools against accident and misuse, and avoid impeding immense potential benefits.

PLoS Computational BiologyVol. 21(5)
Johns Hopkins University (US), Fordham University (US), Stanford Health Care (US), Stanford Medicine (US), Carnegie Mellon University (US), Stanford University (US)
Openalex Percentile: Top 1%
Bacillus and Francisella bacterial research
12.90
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.